STANFORD UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1885-11-11

Employees: 10K

Market Cap: -

Website: http://www.stanford.edu

Clinical Trials

Intensive Cryotherapy in the Emergency Department for Acute Musculoskeletal Injuries

Not Applicable

Completed

Conditions: Opiate
Emergency
Pain

Interventions: Procedure: Intensive cryotherapy

First Posted Date: 2016-03-25

Last Posted Date: 2019-11-06

Lead Sponsor: Stanford University

Target Recruit Count: 38

Registration Number: NCT02720315

Provider Alerts to Reduce Unnecessary Care

Not Applicable

Completed

Conditions: Physician's Role

Interventions: Behavioral: Electronic Record Alert

First Posted Date: 2016-03-16

Last Posted Date: 2021-06-14

Lead Sponsor: Stanford University

Target Recruit Count: 50

Registration Number: NCT02709772

In Infants With Laryngomalacia, Does Acid-Blocking Medication Improve Respiratory Symptoms?

Not Applicable

Withdrawn

Conditions: Acid Reflux
Stridor
Laryngomalacia

Interventions: Drug: ranitidine or famotidine
Drug: Placebo

First Posted Date: 2016-03-07

Last Posted Date: 2017-11-17

Lead Sponsor: Stanford University

Registration Number: NCT02700087

Locations: 🇺🇸
Lucile Packard Children's Hospital Stanford, Palo Alto, California, United States

[18F]FMISO PET/CT After Transcatheter Arterial Embolization in Imaging Tumors in Patients With Liver Cancer

Phase 2

Completed

Conditions: Liver Cirrhosis
Adult Liver Carcinoma

Interventions: Drug: 18F-Fluoromisonidazole
Procedure: Arterial Embolization
Diagnostic Test: Computed Tomography
Diagnostic Test: Positron Emission Tomography

First Posted Date: 2016-03-01

Last Posted Date: 2024-01-31

Lead Sponsor: Stanford University

Target Recruit Count: 5

Registration Number: NCT02695628

Locations: 🇺🇸
VA Palo Alto Healthcare System, Palo Alto, California, United States

CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation Therapy

Phase 1

Completed

Conditions: Malignant Lung Neoplasm
Stage IV Lung Cancer
Non-Small Cell Lung Carcinoma
Metastatic Malignant Neoplasm in the Lung

Interventions: Device: CAPP-Seq
Drug: Isovue-200
Radiation: Computed Tomography Perfusion Imaging

First Posted Date: 2016-02-26

Last Posted Date: 2023-11-22

Lead Sponsor: Stanford University

Target Recruit Count: 19

Registration Number: NCT02693080

Locations: 🇺🇸
Stanford University, School of Medicine, Palo Alto, California, United States

Bilirubin Binding Capacity to Assess Bilirubin Load in Preterm Infants

Completed

Conditions: Hyperbilirubinemia
Bilirubin-induced Neurologic Dysfunction
Infant, Low Birth Weight
Kernicterus
Infant, Premature

Interventions: Diagnostic Test: Bilirubin Binding Capacity
Diagnostic Test: End-tidal Carbon Monoxide
Diagnostic Test: Carboxyhemoglobin

First Posted Date: 2016-02-25

Last Posted Date: 2021-10-01

Lead Sponsor: Stanford University

Target Recruit Count: 143

Registration Number: NCT02691156

Locations: 🇺🇸
Lucile-Packard Children's Hospital at Stanford, Stanford, California, United States

Evaluation of Extended Infusion Set Wear Using Medtronic Extended Wear Sof-set Infusion Set

Phase 1

Completed

Conditions: Type 1 Diabetes

Interventions: Device: Extended Wear infusion set
Device: Standard Infusion set
Drug: Heparin

First Posted Date: 2016-02-22

Last Posted Date: 2018-06-06

Lead Sponsor: Stanford University

Target Recruit Count: 24

Registration Number: NCT02687256

Locations: 🇺🇸
Stanford University, Palo Alto, California, United States

Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers

Early Phase 1

Completed

Conditions: Healthy Subject
Pancreatic Carcinoma

Interventions: Diagnostic Test: Computed Tomography
Other: Laboratory Biomarker Analysis
Diagnostic Test: PET/MRI scan
Drug: [18F]FP-R01-MG-F2

First Posted Date: 2016-02-17

Last Posted Date: 2023-09-21

Lead Sponsor: Stanford University

Target Recruit Count: 21

Registration Number: NCT02683824

Locations: 🇺🇸
Stanford University, School of Medicine, Palo Alto, California, United States

Mifepristone Versus Osmotic Dilators in Conjunction With Misoprostol for Cervical Preparation Prior to D&E at 14-19 Weeks

Not Applicable

Withdrawn

Conditions: Legally Induced Abortion Without Mention of Complication

Interventions: Device: Hygroscopic cervical dilators
Drug: Misoprostol
Drug: Mifepristone

First Posted Date: 2016-02-10

Last Posted Date: 2019-09-19

Lead Sponsor: Stanford University

Registration Number: NCT02679092

Locations: 🇺🇸
Planned Parenthood Mar Monte, San Jose, California, United States

Safety and Efficacy of Oral Treprostinil in the Treatment of Calcinosis in Patients With Systemic Sclerosis

Phase 2

Completed

Conditions: Systemic Sclerosis
Calcinosis

Interventions: Drug: Oral treprostinil

First Posted Date: 2016-01-26

Last Posted Date: 2021-06-10

Lead Sponsor: Stanford University

Target Recruit Count: 12

Registration Number: NCT02663895

Locations: 🇺🇸
Stanford University School of Medicine, Palo Alto, California, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy